This topic contains a solution. Click here to go to the answer

Author Question: Which of the following can be monitored with the Maquet Servoi? 1. Inspiratory and expiratory ... (Read 80 times)

Capo

  • Hero Member
  • *****
  • Posts: 545
Which of the following can be monitored with the Maquet Servoi? 1. Inspiratory and expiratory resistance 2. Patient work of breathing 3. Work of breathing associated with the ventilator 4. Electrical activity of the diaphragm
 
  a. 1 and 3 c. 1, 3, and 4
  b. 2 and 3 d. 1, 2, 3, and 4

Question 2

What is the respiratory rate available on the CareFusion SiPAP?
 
  a. 1 to 100 breaths/minute c. 1 to 150 breaths/minute
  b. 1 to 125 breaths/minute d. 1 to 200 breaths/minute



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

paavo

  • Sr. Member
  • ****
  • Posts: 301
Answer to Question 1

ANS: D
Advanced monitoring capabilities of the Maquet Servoi include measurement of the inspiratory and expiratory resistance, patient work of breathing, the work of breathing associated with the ventilator, and electrical activity of the diaphragm.

Answer to Question 2

ANS: C
The respiratory rate on the CareFusion SiPAP is adjustable from 0 to 150 breaths per minute.




Capo

  • Member
  • Posts: 545
Reply 2 on: Jul 16, 2018
Great answer, keep it coming :)


ttt030911

  • Member
  • Posts: 315
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

The heart is located in the center of the chest, with part of it tipped slightly so that it taps against the left side of the chest.

Did you know?

Nitroglycerin is used to alleviate various heart-related conditions, and it is also the chief component of dynamite (but mixed in a solid clay base to stabilize it).

Did you know?

The ratio of hydrogen atoms to oxygen in water (H2O) is 2:1.

Did you know?

In 2010, opiate painkllers, such as morphine, OxyContin®, and Vicodin®, were tied to almost 60% of drug overdose deaths.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library